Arrowpoint Investment Partners »

Biontech Se shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Biontech Se (BNTX) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Biontech Se

Tip: Access up to 7 years of quarterly data

All positions including Biontech Se held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biontech Se by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $612k 6.9k 88.88

More positions owned by Arrowpoint Investment Partners

Ishares Tr Expanded Tech Call Option (IGV)
Kraneshares Trust Csi Chi Internet (KWEB)
Alphabet Cap Stk Cl A (GOOGL)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Ishares Msci Brazil Etf Call Option (EWZ)
Ase Technology Hldg Sponsored Ads (ASX)
Ionis Pharmaceuticals (IONS)
Neurocrine Biosciences (NBIX)
Axsome Therapeutics (AXSM)
BioMarin Pharmaceutical (BMRN)
Ascendis Pharma A/s Sponsored Adr (ASND)
Ptc Therapeutics I (PTCT)
Pfizer (PFE)
Regeneron Pharmaceuticals (REGN)
Johnson & Johnson (JNJ)

View all positions for Arrowpoint Investment Partners

Top funds holding Biontech Se

FMR
T. Rowe Price Investment Management
PRIMECAP Management Company
Flossbach Von Storch
Dodge & Cox
BlackRock
Bnp Paribas Arbitrage, Snc
Citadel Advisors
Temasek Holdings
Bank of America Corporation
Baillie Gifford & Co
First Trust Advisors
Ubs Global Asset Management Americas
Susquehanna International
Massachusetts Financial Services

View all funds holding Biontech Se